Summary of Study ST000881

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000611. The data can be accessed directly via it's Project DOI: 10.21228/M8XQ41 This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  |  Perform analysis on untargeted data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST000881
Study TitleTargeted metabolomics data of leprosy patients with type 1 reaction
Study TypeTargeted MS/MS analysis in retrospective serum samples of leprosy patients with type 1 reaction
Study SummaryTargeted metabolomics-based analyses of pooled sera from 7 patients with T1R were conducted via LC-MS/MS.
Institute
Colorado State University
DepartmentDepartment of Microbiology, Immunology, and Pathology
LaboratoryBelisle
Last NameSilva
First NameCarlos
AddressRampart Road, 1682 Campus Delivery
Emailcadriano@rams.colostate.edu
Phone9702154962
Submit Date2017-08-02
Num Groups2
Total Subjects16
Num Males5
Num Females11
Study Comments2 groups (first group was leprosy patients with type 1 reaction, N=9; and second group was leprosy patients without type 1 reaction, N=7) 5 males (3 were leprosy patients with type 1 reaction and 2 were leprosy patients without type 1 reaction), 11 females (4 were leprosy patients with type 1 reaction and 7 were leprosy patients without type 1 reaction). For this study we used retrospective sera samples.
PublicationsJ Infect Dis. 2017 Feb 1;215(3):431-439. doi: 10.1093/infdis/jiw541.
Raw Data AvailableYes
Raw Data File Type(s)d
Analysis Type DetailLC-MS
Release Date2017-08-02
Release Version1
Carlos Silva Carlos Silva
https://dx.doi.org/10.21228/M8XQ41
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Project:

Project ID:PR000611
Project DOI:doi: 10.21228/M8XQ41
Project Title:Metabolomics analysis of leprosy patients with type 1 reaction
Project Type:MS qualitative analysis and identification of polyunsaturated fatty acids in retrospective serum samples of leprosy patients with type 1 reaction
Project Summary:Type 1 reaction (T1R) is an acute inflammatory episode that causes severe neuronal damages in patients with leprosy. The factors that trigger this pathology is still unknown, and further studies are needed to understand T1R and to early prevent its start. It is well established that the host immune response is linked to T1R and previous studies indicated that the metabolism of the host also influences the adaptive immune response against M. leprae antigens. Therefore, metabolomics-based analyses of sera from 7 patients with and 9 without T1R were conducted via liquid chromatography–mass spectrometry. The main goal of this project was to determine whether the metabolism of polyunsaturated fatty acids (such as eicosanoids and omega-3 fatty acids) were perturbed in leprosy patients with T1R.
Institute:Colorado State University
Department:Department of Microbiology, Immunology, and Pathology
Laboratory:Belisle
Last Name:Belisle
First Name:John
Address:Rampart Road, 1682 Campus Delivery
Email:cadriano@rams.colostate.edu
Phone:9704819160
Funding Source:This work was supported by the New York Community Trust (grant to J. T. B. as co–principle investigator [PI]), by the Heiser Foundation (grant to J. T. B. as co-PI), and by the Brazilian Coordination for the Improvement of Higher Education Personnel through the Science without Borders program (10546-13-8, for the postdoctoral scholarship to C. A. M. S.).
Project Comments:The institutional review boards of Colorado State University approved the use of sera for the reported study.
Publications:J Infect Dis. 2017 Feb 1;215(3):431-439. doi: 10.1093/infdis/jiw541.
Contributors:Carlos A. M. Silva, Kristofor Webb, Barbara G. Andre, Maria Angela Marques, Fernanda Marques Carvalho, Cristiana Santos de Macedo, Roberta Olmo Pinheiro, Euzenir Nunes Sarno, Maria Cristina Vidal Pessolani, John T. Belisle.
  logo